NATCO Pharma Limited (NATCOPHARM.BO)
INR 1475.25
(2.03%)
INR 1475.25
(2.03%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 77.34 INR | 97.4% |
| 2022 | 39.18 INR | 320.39% |
| 2021 | 9.32 INR | -61.49% |
| 2020 | 24.20 INR | -4.46% |
| 2019 | 25.33 INR | -27.59% |
| 2018 | 34.98 INR | -10.9% |
| 2017 | 39.26 INR | 40.77% |
| 2016 | 27.89 INR | 205.14% |
| 2015 | 9.14 INR | 12.42% |
| 2014 | 8.13 INR | 26.44% |
| 2013 | 6.43 INR | 39.78% |
| 2012 | 4.60 INR | 11.92% |
| 2011 | 4.11 INR | 8.16% |
| 2010 | 3.80 INR | 9.83% |
| 2009 | 3.46 INR | 10.19% |
| 2008 | 3.14 INR | 8.65% |
| 2007 | 2.89 INR | 31.36% |
| 2006 | 2.20 INR | 25.71% |
| 2005 | 1.75 INR | 1358.33% |
| 2004 | 0.12 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 37.32 INR | 73.1% |
| 2023 Q3 | 11.88 INR | -42.36% |
| 2023 Q1 | 23.26 INR | 53.94% |
| 2023 Q2 | 20.61 INR | -11.39% |
| 2023 Q4 | 21.56 INR | 81.48% |
| 2023 FY | - INR | 97.4% |
| 2022 Q3 | 3.41 INR | 9.65% |
| 2022 Q4 | 15.11 INR | 343.11% |
| 2022 FY | - INR | 320.39% |
| 2022 Q1 | 17.56 INR | 733.94% |
| 2022 Q2 | 3.11 INR | -82.29% |
| 2021 Q4 | -2.77 INR | -162.81% |
| 2021 Q1 | 4.11 INR | 41.24% |
| 2021 FY | - INR | -61.49% |
| 2021 Q2 | 3.57 INR | -13.14% |
| 2021 Q3 | 4.41 INR | 23.53% |
| 2020 Q1 | 6.74 INR | 30.37% |
| 2020 Q2 | 11.12 INR | 64.99% |
| 2020 Q3 | 3.44 INR | -69.06% |
| 2020 Q4 | 2.91 INR | -15.41% |
| 2020 FY | - INR | -4.46% |
| 2019 Q3 | 5.75 INR | -12.21% |
| 2019 FY | - INR | -27.59% |
| 2019 Q4 | 5.17 INR | -10.09% |
| 2019 Q2 | 6.55 INR | -16.77% |
| 2019 Q1 | 7.87 INR | 19.42% |
| 2018 Q4 | 6.59 INR | -23.82% |
| 2018 Q3 | 8.65 INR | -12.54% |
| 2018 Q2 | 9.89 INR | 0.51% |
| 2018 FY | - INR | -10.9% |
| 2018 Q1 | 9.84 INR | -39.48% |
| 2017 FY | - INR | 40.77% |
| 2017 Q1 | 5.59 INR | -44.65% |
| 2017 Q4 | 16.26 INR | 32.3% |
| 2017 Q2 | 4.82 INR | -13.77% |
| 2017 Q3 | 12.29 INR | 154.98% |
| 2016 Q4 | 10.10 INR | -9.66% |
| 2016 Q1 | 2.74 INR | -29.02% |
| 2016 Q3 | 11.18 INR | 194.99% |
| 2016 Q2 | 3.79 INR | 38.32% |
| 2016 FY | - INR | 205.14% |
| 2015 Q4 | 3.86 INR | 81.22% |
| 2015 FY | - INR | 12.42% |
| 2015 Q3 | 2.13 INR | 17.68% |
| 2015 Q2 | 1.81 INR | 6.47% |
| 2015 Q1 | 1.70 INR | -42.57% |
| 2014 Q4 | 2.96 INR | 240.23% |
| 2014 Q2 | 1.96 INR | -2.97% |
| 2014 Q1 | 2.02 INR | 39.31% |
| 2014 FY | - INR | 26.44% |
| 2014 Q3 | 0.87 INR | -55.61% |
| 2013 Q2 | 1.72 INR | 23.74% |
| 2013 Q3 | 1.87 INR | 8.72% |
| 2013 FY | - INR | 39.78% |
| 2013 Q1 | 1.39 INR | 93.06% |
| 2013 Q4 | 1.45 INR | -22.46% |
| 2012 Q1 | 1.10 INR | 42.86% |
| 2012 FY | - INR | 11.92% |
| 2012 Q2 | 1.35 INR | 22.73% |
| 2012 Q4 | 0.72 INR | -50.0% |
| 2012 Q3 | 1.44 INR | 6.67% |
| 2011 Q3 | 1.18 INR | 4.42% |
| 2011 FY | - INR | 8.16% |
| 2011 Q2 | 1.13 INR | 0.0% |
| 2011 Q4 | 0.77 INR | -34.75% |
| 2010 FY | - INR | 9.83% |
| 2009 FY | - INR | 10.19% |
| 2008 FY | - INR | 8.65% |
| 2007 FY | - INR | 31.36% |
| 2006 FY | - INR | 25.71% |
| 2005 FY | - INR | 1358.33% |
| 2004 FY | - INR | 0.0% |